An outbreak of Schistosoma mansoni in northern Senegal was observed in 1988, and chemotherapy with praziquantel in this recently established focus resulted in very low parasitologic cure rates. Among other explanations, the emergence of a praziquantel-tolerant parasite strain was feared. To study this hypothesis further, 138 persons with endemic S. mansoni infection were randomly allocated to treatment with either 20 mg/kg oxamniquine or 40 mg/kg praziquantel. Parasitologic cure rates at 6 weeks were significantly higher in the oxamniquine group (79%) compared with those in the praziquantel group (36%; P Å .0043). The reduction in egg counts was generally good, but 12% less reduced in the praziquantel group. These results confirm that cure rates with praziquantel were abnormally low, whereas oxamniquine performed satisfactorily, as in other areas in which S. mansoni is endemic. The possibility of a praziquantel-tolerant S. mansoni strain must therefore be studied carefully.
During the last decade, praziquantel has been the drug of Population and Methods choice for the treatment of intestinal schistosomiasis in Africa
The study village, Ndombo, consists of 3000-4000 inhabitants [1] . This drug is considered to be safe and efficacious. Howand is situated along a main irrigation canal, not far from the town ever, in a Schistosoma mansoni focus in northern Senegal, of Richard-Toll in northern Senegal. The area has been described cure rates after praziquantel treatment were low compared with in detail elsewhere [3] . All study subjects (n Å 138) were residents those in other areas in which S. mansoni is endemic [1, 2] . from this village, and after extensive information about the reThis focus has only recently emerged and is characterized by search and its aims, they volunteered to participate. Each person extremely high intensities of infection [3] . Lack of immunity submitted to a parasitologic examination: 2 stool samples were may also play a role, considering the synergistic action of collected at 2 different days before treatment, and duplicate 25-mg Kato slides were prepared from each sample [6] . The slides praziquantel with host immune responses [4] . However, the were examined 24-72 h after preparation by two microscopists spread of a genetically homogeneous schistosome strain with unaware of the given treatment. Participants were prestratified by low susceptibility to praziquantel cannot be excluded [2, 5] .
age, intensity of infection, and history of previous praziquantel
The aim of the present study was to compare the efficacy of treatment and then randomly allocated to treatment with either 40 praziquantel in this focus with that of another schistosomicidal mg/kg praziquantel (Distocide; Shin Poong, Seoul, Korea) or 20 drug, oxamniquine, in a controlled field trial. mg/kg oxamniquine (Vansil; Pfizer, Groton, CT) by lottery. Pregnant women and children õ5 years old were excluded from the study. Parasitologic examination was repeated at 3 and 6 weeks after treatment. with respect to age, sex, intensity of infection, and history of the chemotherapeutic field trials was a comparison between previous treatment. According to the parasitologic data, subpraziquantel and oxamniquine. Normally, both drugs are jects treated with oxamniquine showed significantly better cure equally effective against S. mansoni; however, if important rates at 6 weeks after treatment than did those who received differences in cure between the two drugs were to be found, praziquantel: 79% versus 36% (P Å .0043; figure 1 ). The reducthey might be caused by regional parasite strain characteristics. tion in egg counts 6 weeks after treatment was higher in the The potential emergence of a parasite strain less susceptible oxamniquine group than in the praziquantel group: 94% versus to praziquantel treatment has been extensively debated [8] . 82% (figure 2).
Although praziquantel resistance has never been reported in other areas in which schistosomiasis is endemic, the epidemic nature of this focus may have caused a homogeneous and Discussion praziquantel-tolerant strain to become apparent. The existence of strain-related variations in tolerance was described for differTreatment with praziquantel normally results in cure rates ent antimonial drugs [9] ; however, this phenomenon was only between 60% and 95% [2] . However, in this focus in northern recently reported for praziquantel by Fallon and Doenhoff [10] . Senegal, treatment with the standard drug regimen of 40 mg/ In a laboratory setting, they were able to select a schistosome kg resulted in a parasitologic cure of only 18% -36%, destrain not susceptible to praziquantel, but this characteristic did pending on the follow-up period after treatment [2, 7] . Various not remain constant when the drug pressure was removed. explanations could be forwarded, such as the very high intensiAdditionally, in the same setting, 1 isolate from the Senegal ties of infection and the recent nature of this focus; however, focus appeared to be more tolerant to praziquantel treatment after several in-depth studies, these possibilities could be re- [5] . We therefore compared praziquantel with oxamniquine in jected (unpublished data). The most important component of a field study, as oxamniquine is considered as effective as praziquantel for community treatment [11] . The best follow-up period for monitoring parasitologic cure has been a topic of discussion [8] . Six weeks is considered the optimal follow-up period for the evaluation of schistosomiasis treatment, as this is the ''parasitologic window'' in which most eggs from previous infections would be excreted and eggs from prepatent infections would not yet have appeared. At the 6-week follow-up in this focus, the parasitologic cure rate obtained by oxamniquine treatment was significantly better than that of praziquantel and, in contrast to praziquantel, highly comparable with what has been observed in other areas [1, 12] .
Prepatent infections may explain in part the difference in cure, as such infections become susceptible to praziquantel treatment 1 week later than they become susceptible to oxamniquine treatment [13] . However, after the randomization procedure, the oxamniquine group still possessed higher intensities of infection and therefore probably maintained even more pre- Egg count reduction in subjects who did not achieve cure after treatment with either praziquantel (n Å 42) or oxamniquine (n Å 15), before and 6 weeks after treatment.
rates or at least cure rates similar to those of the praziquantel cantly better than after 40 mg/kg praziquantel. This observation supports the hypothesis about a Senegalese schistosome strain group. Furthermore, in the focus of Maniema, Zaire, intensities of infection equally high as those in this Senegalese focus were with an increased tolerance to the latter drug. To still be able to design adequate control strategies in the future, further studies encountered [12] . However, in the Zairian focus, cure rates after oxamniquine treatment were inferior to those obtained by should be undertaken to verify this hypothesis, and efforts should be made to understand the underlying mechanisms of praziquantel treatment [12] . An abundance of prepatent infections alone can thus not sufficiently explain the low parasitothis phenomenon. logic cure rates observed after praziquantel treatment in this Senegalese schistosomiasis focus.
The different working mechanisms of praziquantel and ox-
